Blogs and social media sites are rich with valuable conversations on health conditions, treatment experiences, and emotional support, but without clear FDA guidance, pharmaceutical companies are unsure how to conduct monitoring and marketing in social media.
This webinar will provide a framework marketing, compliance and legal staff can agree on to reduce the potential for creating regulatory compliance problems.
Join us to discuss:
- adverse event reporting
- potential risks with off-label promotion
- achieving a fair balance in social media marketing programs
Official Website: https://cymfony.webex.com/cymfony/onstage/g.php?t=a&d=759502513
Added by brian cavoli on August 20, 2007